DC-PMAT
Sponsors
Second Military Medical University
Conditions
Advanced Hepatocellular CarcinomaGastric CancerLiver Metastasis
Phase 1
Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis
NCT02632201
Start: 2015-09-30End: 2017-09-30Target: 40Updated: 2016-01-01
Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma
NCT02632006
Start: 2015-09-30End: 2017-09-30Target: 40Updated: 2016-01-01